Urinary Oxidative Stress Markers Closely Reflect the Efficacy of Candesartan Treatment for Diabetic Nephropathy

Publisher： Karger

E-ISSN： 1660-2129|111|1|e20-e30

ISSN： 1660-2129

Source： Nephron Experimental Nephrology, Vol.111, Iss.1, 2008-12, pp. : e20-e30

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Telmisartan Attenuates Diabetic Nephropathy by Suppressing Oxidative Stress in db/db Mice

By  

Nephron Experimental Nephrology, Vol. 121, Iss. 3-4, 2013-01 ,pp. : e97-e108

Karger

Access to resources Recommend Favorite

Amelioration of Established Diabetic Nephropathy by Combined Treatment with SMP-534 (Antifibrotic Agent) and Losartan in db/db Mice

By  

Nephron Experimental Nephrology, Vol. 105, Iss. 2, 2006-11 ,pp. : e45-e52

Karger

Access to resources Recommend Favorite

Beneficial Effect of TGFβ Antagonism in Treating Diabetic Nephropathy Depends on When Treatment Is Started

By  

Nephron Experimental Nephrology, Vol. 104, Iss. 4, 2006-08 ,pp. : e158-e168

Karger

Access to resources Recommend Favorite

Differential Effects of Transient Treatment of Spontaneously Hypertensive Rats with Various Antihypertensive Agents on the Subsequent Development of Diabetic Nephropathy

By  

Nephron Experimental Nephrology, Vol. 109, Iss. 1, 2008-05 ,pp. : e20-e28

Karger

Access to resources Recommend Favorite

Effects of Simvastatin on Oxidative Stress in Streptozotocin-Induced Diabetic Rats: A Role for Glomeruli Protection

By  

Nephron Experimental Nephrology, Vol. 101, Iss. 1, 2005-05 ,pp. : e1-e8

Karger

Access to resources Recommend Favorite